BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27117437)

  • 1. Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study.
    MacLeod N; Kelly C; Stobo J; McMahon L; Taggart D; Fallon M; Laird BJ
    Pain Med; 2016 Nov; 17(11):2119-2126. PubMed ID: 27117437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
    J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing.
    Gierthmühlen J; Schneider U; Seemann M; Freitag-Wolf S; Maihöfner C; Enax-Krumova EK; Azad SC; Üçeyler N; Birklein F; Maier C; Tölle T; Treede RD; Baron R
    Pain; 2019 Sep; 160(9):2093-2104. PubMed ID: 31162335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
    Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
    Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity, reliability, and assessment sensitivity of the Japanese version of the short-form McGill pain questionnaire 2 in Japanese patients with neuropathic and non-neuropathic pain.
    Maruo T; Nakae A; Maeda L; Shi K; Takahashi K; Morris S; Hosomi K; Kanatani H; Matsuzaki T; Saitoh Y
    Pain Med; 2014 Nov; 15(11):1930-7. PubMed ID: 24930826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of chronic pain after non-traumatic, non-compressive myelopathy: Focus on neuropathic pain.
    Eom YI; Kim M; Joo IS
    J Spinal Cord Med; 2017 May; 40(3):268-274. PubMed ID: 27577060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
    Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
    Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for neuropathic characteristics in failed back surgery syndromes: challenges for guiding treatment.
    Markman JD; Kress BT; Frazer M; Hanson R; Kogan V; Huang JH
    Pain Med; 2015 Mar; 16(3):520-30. PubMed ID: 25530081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the S-LANSS in the community setting.
    Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
    Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study.
    Haroun OMO; Hietaharju A; Bizuneh E; Tesfaye F; Brandsma WJ; Haanpää M; Rice ASC; Lockwood DNJ
    Pain; 2012 Aug; 153(8):1620-1624. PubMed ID: 22727538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.
    Dyal BW; Ezenwa MO; Yoon SL; Fillingim RB; Yao Y; Schlaeger JM; Suarez ML; Wang ZJ; Molokie RE; Wilkie DJ
    Pain Pract; 2020 Feb; 20(2):168-178. PubMed ID: 31553824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the LANSS scale be used to classify pain in chronic cancer pain trials?
    Hardy J; Quinn S; Fazekas B; Agar M; Currow D
    Support Care Cancer; 2013 Dec; 21(12):3387-91. PubMed ID: 23934225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
    Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
    Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
    Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
    Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting.
    Isomura T; Sumitani M; Matsudaira K; Kawaguchi M; Inoue R; Hozumi J; Tanaka T; Oshima H; Mori K; Taketomi S; Inui H; Tahara K; Yamagami R; Hayakawa K
    Pain Pract; 2017 Jul; 17(6):800-807. PubMed ID: 27770598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.